A5086108893- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Practices and Patient Outcomes
- Health and Medical Studies
- Frailty in Older Adults
- Intensive Care Unit Cognitive Disorders
- Pharmaceutical studies and practices
- Blood Pressure and Hypertension Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Medication Adherence and Compliance
- Nutrition and Health in Aging
- Rheumatoid Arthritis Research and Therapies
- Medical Practices and Rehabilitation
- Heart Failure Treatment and Management
- Electrolyte and hormonal disorders
- Reproductive Physiology in Livestock
- Clinical practice guidelines implementation
- Chronic Kidney Disease and Diabetes
- Physics and Engineering Research Articles
- Pain Management and Opioid Use
- Psychiatric care and mental health services
- Venous Thromboembolism Diagnosis and Management
- Dialysis and Renal Disease Management
- Cardiovascular Syncope and Autonomic Disorders
- Metabolism and Genetic Disorders
- Chronic Disease Management Strategies
University Medical Centre Mannheim
2015-2024
Heidelberg University
2015-2024
University Hospital Heidelberg
2015-2024
Medizinische Fakultät Mannheim
2011-2019
University of Mannheim
2019
Goethe University Frankfurt
2015-2018
Fraunhofer Institute for Translational Medicine and Pharmacology
2017-2018
University Hospital Frankfurt
2018
Fraunhofer Institute for Molecular Biology and Applied Ecology
2017
King's College London
2012
Trial design: to further validate the FORTA (Fit fOR The Aged) concept, a bicentric randomised, controlled trial was run in two geriatric clinics. Methods: patients (≥65 years, ≥3 drugs or ≥60 ≥6 drugs) with three relevant diseases and hospitalisation for ≥5 days were randomised. In intervention, but not control group, team instructed ward physicians on FORTA. is first positive/negative listing approach labelling medications used treat chronic illnesses older from A (indispensable), B...
<i>Background:</i> The aim of this study was to assess the accuracy and precision estimators true glomerular filtration rate (GFR) (Cockcroft formula, measured creatinine clearance (CCR) a cystatin-C-based estimation) in elderly patients attending geriatric department. Additionally, parameters influencing GFR were evaluated. <i>Methods:</i> 30 aged 57–90 years treated Geriatric Department for pulmonary or cerebral diseases included study. Nine diabetic 16...
To evaluate the quality of bedside estimation glomerular filtration rate (GFR) in hospitalized elderly patients.We evaluated common estimators GFR 29 women and 32 men aged 60 older a geriatric ward: creatinine clearance (CCR), Cockcroft-Gault formula (CG), modification diet renal disease (MDRD), Baracskay (BAR), newly developed derived recently by us (GCM). Inulin (CINU) was used to assess GFR. Exclusion criteria were mental illness urinary incontinence.According Bland Altman accuracy...
Abstract Background Older people represent a risk group for acquiring or further development of delirium during hospitalization, therefore requiring suitable nonpharmacological interventions. Objective This scoping review analyzed intervention programs older inpatients with without cognitive decline on regular acute geriatric wards to present the range Methods A systematic literature search was conducted using scientific databases. total 4652 records were screened by two independent...
This is a secondary analysis of data from cross-sectional study to evaluate the diagnostic efficiency cystatin C as marker glomerular filtration rate in elderly. Thirty patients (15 male, 15 female, mean age 75.4±7.1 years) attending geriatric ward were enrolled. Exclusion criteria previously diagnosed renal disease, dementia and heart failure (NYHA III or IV). Cystatin serum was determined by particle-enhanced turbidimetric assay. Inulin clearance assessed using single-shot method. Also,...
Previous investigations in patients with coronary artery disease (CAD) revealed differences thromboelastographic parameters indicating different states of coagulability. The aim the present study was to investigate coagulation status documented CAD and type II diabetes mellitus (DM) non-diabetic PFA-100® ROTEM®. No were found platelet function as measured collagen/epinephrine (263.6 ± 70.6 s vs. 254.6 65.3 s) collagen/ADP cartridges (105.3 63.2 90.6 47.3 DM without DM. Measured EXTEM reagent...